Banu Nasirah, Chia Adeline, Ho Zi Zong, Garcia Alfonso Tan, Paravasivam Komathi, Grotenbreg Gijsbert M, Bertoletti Antonio, Gehring Adam J
Singapore Institute for Clinical Sciences, Agency for Science Technology and Research (A*Star), Singapore.
Departments of Microbiology and Biological Sciences, Immunology Programme, National University of Singapore, Singapore.
Sci Rep. 2014 Feb 25;4:4166. doi: 10.1038/srep04166.
Restoration of antigen-specific T cell immunity has the potential to clear persistent viral infection. T cell receptor (TCR) gene therapy can reconstitute CD8 T cell immunity in chronic patients. We cloned 10 virus-specific TCRs targeting 5 different viruses, causing chronic and acute infection. All 10 TCR genetic constructs were optimized for expression using a P2A sequence, codon optimization and the addition of a non-native disulfide bond. However, maximum TCR expression was only achieved after establishing the optimal orientation of the alpha and beta chains in the expression cassette; 9/10 TCRs favored the beta-P2A-alpha orientation over alpha-P2A-beta. Optimal TCR expression was associated with a significant increase in the frequency of IFN-gamma+ T cells. In addition, activating cells for transduction in the presence of Toll-like receptor ligands further enhanced IFN-gamma production. Thus, we have built a virus-specific TCR library that has potential for therapeutic intervention in chronic viral infection or virus-related cancers.
恢复抗原特异性T细胞免疫有清除持续性病毒感染的潜力。T细胞受体(TCR)基因疗法可在慢性患者中重建CD8 T细胞免疫。我们克隆了10种针对5种不同病毒的病毒特异性TCR,这些病毒可引起慢性和急性感染。所有10种TCR基因构建体都使用P2A序列、密码子优化和添加非天然二硫键进行了表达优化。然而,只有在确定表达盒中α链和β链的最佳方向后,才能实现TCR的最大表达;10种TCR中有9种倾向于β-P2A-α方向而非α-P2A-β方向。最佳TCR表达与IFN-γ+ T细胞频率的显著增加相关。此外,在Toll样受体配体存在的情况下激活用于转导的细胞可进一步增强IFN-γ的产生。因此,我们构建了一个病毒特异性TCR文库,其在慢性病毒感染或病毒相关癌症的治疗干预方面具有潜力。